>
Switch to:

Turning Point Therapeutics EV-to-Revenue

: 98.57 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Turning Point Therapeutics's enterprise value is $2,464.16 Mil. Turning Point Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $25.00 Mil. Therefore, Turning Point Therapeutics's EV-to-Revenue for today is 98.57.

NAS:TPTX' s EV-to-Revenue Range Over the Past 10 Years
Min: 91.47   Med: 156.74   Max: 204.52
Current: 98.56

91.47
204.52

During the past 4 years, the highest EV-to-Revenue of Turning Point Therapeutics was 204.52. The lowest was 91.47. And the median was 156.74.

NAS:TPTX's EV-to-Revenue is ranked lower than
73% of the 926 Companies
in the Biotechnology industry.

( Industry Median: 22.98 vs. NAS:TPTX: 98.56 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-04-23), Turning Point Therapeutics's stock price is $72.9. Turning Point Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.59. Therefore, Turning Point Therapeutics's PS Ratio for today is 122.93.


Turning Point Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
EV-to-Revenue 0.00 0.00 0.00 192.51

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 192.51

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Turning Point Therapeutics's EV-to-Revenue falls into.



Turning Point Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Turning Point Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2464.163/25
=98.57

Turning Point Therapeutics's current Enterprise Value is $2,464.16 Mil.
Turning Point Therapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 25 (Sep. 2020 ) + 0 (Dec. 2020 ) = $25.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Turning Point Therapeutics  (NAS:TPTX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Turning Point Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=72.9/0.593
=122.93

Turning Point Therapeutics's share price for today is $72.9.
Turning Point Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0.593 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0.59.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Turning Point Therapeutics EV-to-Revenue Related Terms


Turning Point Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)